Natural cytotoxicity in malignant and premalignant cervical neoplasia and enhancement of cytotoxicity with interferon.
Natural cytotoxicity was measured in 70 women with cervical dysplasia or invasive cervical cancer and in 13 controls, using a short-term chromium release assay. A significant diminution in mean cytotoxicity was found in women with CIN III and with advanced cervical carcinoma. When the peripheral blood leukocytes of patients and controls were pretreated with interferon, there was significant enhancement of the mean cytotoxicity for all groups except those with advanced cervical carcinoma (stage IIB or worse). Our results have shown a significant defect in a potentially important immune surveillance mechanism in a group of patients with premalignant disease at risk for the development of invasive cancer. A possible role for interferon in the treatment of cervical intraepithelial neoplasia is suggested.
D000328:Adult; D000368:Aged; D002278:Carcinoma in Situ / Q000276:immunology; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000494:pharmacology; D007372:Interferons / Q000494:pharmacology*; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D007962:Leukocytes / Q000166:cytology; D008875:Middle Aged; D002578:Uterine Cervical Dysplasia / Q000276:immunology* / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000276:immunology* / Q000628:therapy
D007370:Interferon Type I; D007372:Interferons